AstraZeneca, the British-Swedish drugmaker which has partnered with Oxford University for a covid vaccine, foresees results from the late-stage trials on its experimental COVID-19 vaccine later this year, depending on the rate of infection among trial participants.
AstraZeneca/Oxford is running with Pfizer/BioNTech, Moderna and others to issue the initial complete results from large COVID-19 vaccine trials. A vaccine is perceived as the world’s safest bet for beating the pandemic.
AstraZeneca has secured billions in funding and approved multiple contracts to supply over three billion doses to countries in the world. Nevertheless, a UK official said on Wednesday the delivery timetable for shots had slipped.
According to forecast figures in the annual infrastructure indicators report, in 2023, the number of…
Several migrants of different nationalities died in the sinking of a boat on the night…
The Prosecutor's Office of the Manouba Court of First Instance authorized, Saturday, the arrest of…
Intelligence units from the National Guard districts of Ghardimaou, Tabarka, Mater, Sbeitla and Grombalia, with…
Iran's Interior Minister Ahmed Vahidi confirmed that a helicopter in the convoy carrying President Ebrahim…
A helicopter carrying Iran's President Ebrahim Raisi and several officials, including Foreign Minister Hossein Amir-Abdollahian,…
This website uses cookies.